APREA THERAPEUTICS INC's ticker is APRE and the CUSIP is 03836J102. A total of 42 filers reported holding APREA THERAPEUTICS INC in Q1 2022. The put-call ratio across all filers is 0.02 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2022 | $48 | -100.0% | 149,711 | -0.3% | 0.00% | – |
| Q3 2022 | $97,000 | -12.6% | 150,142 | 0.0% | 0.00% | – |
| Q2 2022 | $111,000 | -60.2% | 150,142 | 0.0% | 0.00% | – |
| Q1 2022 | $279,000 | -35.1% | 150,142 | -0.0% | 0.00% | – |
| Q4 2021 | $430,000 | -57.6% | 150,143 | -24.3% | 0.00% | – |
| Q3 2021 | $1,013,000 | +99.0% | 198,339 | +89.9% | 0.00% | – |
| Q2 2021 | $509,000 | -38.0% | 104,447 | -35.2% | 0.00% | – |
| Q1 2021 | $821,000 | +13.1% | 161,147 | +9.1% | 0.00% | – |
| Q4 2020 | $726,000 | -77.4% | 147,690 | +10.8% | 0.00% | -100.0% |
| Q3 2020 | $3,208,000 | -22.1% | 133,337 | +25.6% | 0.00% | 0.0% |
| Q2 2020 | $4,117,000 | +23.3% | 106,167 | +10.5% | 0.00% | 0.0% |
| Q1 2020 | $3,340,000 | -58.3% | 96,114 | -45.0% | 0.00% | 0.0% |
| Q4 2019 | $8,016,000 | – | 174,684 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Versant Venture Management, LLC | 1,259,662 | $6,437,000 | 2.66% |
| COASTAL INVESTMENT MANAGEMENT, L.P. | 41,965 | $214,000 | 0.30% |
| Redmile Group, LLC | 694,918 | $3,551,000 | 0.06% |
| Quantamental Technologies LLC | 13,752 | $70,000 | 0.05% |
| KENNEDY CAPITAL MANAGEMENT LLC | 342,486 | $1,750,000 | 0.04% |
| PDT Partners, LLC | 87,734 | $448,000 | 0.03% |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC | 75,000 | $383,000 | 0.01% |
| SUSQUEHANNA FUNDAMENTAL INVESTMENTS, LLC | 49,100 | $251,000 | 0.01% |
| NEXT Financial Group, Inc | 11,347 | $58,000 | 0.01% |
| Sugarloaf Wealth Management, LLC | 1,500 | $8,000 | 0.00% |